Wu Xu-feng, Chen Hui-zhen, Han Ding-fen
Department of Gynecologic Oncology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Zhonghua Fu Chan Ke Za Zhi. 2003 Nov;38(11):664-6.
To investigate the diagnosis, treatment and prognosis of recurrent epithelial ovarian carcinoma.
Fifty-two patients with recurrent epithelial ovarian carcinoma who were admitted in Zhongnan Hospital of Wuhan University between 1997 and 2002 were analyzed retrospectively, and their diagnostic methods and the survival rates were compared.
The positive diagnostic rate of pelvic examination, CA(125) and ultrasound examination was 73.1%, 84.6% and 53.8%, respectively to the recurrent epithelial ovarian carcinoma. The median survival time of group A (surgery + chemotherapy) and group B (chemotherapy) was 11 and 12 months, respectively.
The diagnostic methods should include pelvic examination, CA(125) and ultrasound examination. We could not know the exact role of surgery to the management and prognosis of recurrent epithelial ovarian carcinoma. Chemotherapy may have an important role to the management and prognosis of recurrent epithelial ovarian carcinoma.
探讨复发性上皮性卵巢癌的诊断、治疗及预后。
回顾性分析1997年至2002年武汉大学中南医院收治的52例复发性上皮性卵巢癌患者，比较其诊断方法及生存率。
盆腔检查、CA125及超声检查对复发性上皮性卵巢癌的阳性诊断率分别为73.1%、84.6%和53.8%。A组（手术+化疗）和B组（化疗）的中位生存时间分别为11个月和12个月。
诊断方法应包括盆腔检查、CA125及超声检查。我们尚不清楚手术对复发性上皮性卵巢癌的治疗及预后的确切作用。化疗可能对复发性上皮性卵巢癌的治疗及预后起重要作用。
